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Abstract
Introduction. Available information about the impact of the polymorphic structure of type 1 angiotensin receptor (ATR1) 
gene on the central pulse wave is scarce and contradictory. The aim of the study was to establish a possible association 
of A1166C polymorphism of ATR1 gene with the pulse wave parameters obtained by applanation tonometry.
Material and metods. We examined male and female persons aged 25 to 76 years. They were divided into two groups: 
the basic consisting of 150 hypertensive patients and the control group presented by 128 individuals with normal blood 
pressure. In addition to the general clinical exam three-fold measurements of systolic and diastolic blood pressure 
(systolic blood pressure [SBP] and diastolic blood pressure [DBP], respectively) with the automatic blood pressure 
monitor Omron M3 were provided mandatory. The structure of the polymorphic receptor gene ATR1 was defined in all 
participants by polymerase chain reaction on the thermocycler PHC (Techne, UK). Pulse wave analysis was provided with 
applanation tonometry. For this purpose we used Sphygmocor XCEL equipment (AtCor Medical, Australia).
Results. Analysis of mean SBP and DBP in dependence on ATR1 genotype and existence of arterial hypertension showed 
that there was a tendency to rise with increasing number of C alleles, but statistical significance of the trend had been 
confirmed by ANOVA only for SBP in patients with hypertension. Also it was shown a significant difference in central 
diastolic blood pressure (CDBP) and pulse pressure augmentation (PPA) in hypertensive patients compared with nor-
motensive. It was found a tendency to decrease CDBP and PPA with increasing number of C alleles. The subjects of the 
control group demonstrated the same trend of PPA as in the group of hypertensive patients.
Conclusion. Thus, we established the association between decrease of PPA and increase of C alleles number in the 
ATR1 gene.
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Introduction
Over the last twenty years pulse wave analysis turned from 
exotic procedure into well standardized diagnostic method. 
The role of pulse wave analysis dramatically increased 
due to the number of studies that had shown the ability 
of augmentation index and pulse wave velocity to predict 
the outcome in such conditions as hypertension, corona-
ry heart disease, diabetes and heart failure. It has been 
demonstrated that normalization of central (not peripheral 
[brachial]) blood pressure is associated with the improved 
prognosis for the patients taking antihypertensive drugs 
[1]. Acknowledgement of the role of central pulse wave 
analysis (PWA) was reflected in the recommendations of 
the European Society of Cardiology (ESC) and the European 
Society of Hypertension (ESH) [2]. As the age and blood 
pressure (BP) were found to have the greatest impact on 
the aortic stiffness, the acceptable prediction of pulse wave 
velocity [3] and augmentation index [4] became possible. 
However, other factors were not excluded to have effect 
on the central pulse wave. In particular, the structure of 
type 1 angiotensin receptors (ATR1) may impact pulse wave 
regardless of BP due to their involvement to the formation 
of extracellular matrix and cell growth.
There are numerous publications confirming ATR1 gene 
polymorphism association with BP levels. Adenine/cytosine 
polymorphism in the 3’ non-translated region of gene of 
angiotensin receptor (A1166C) was described by Bonnarde-
aux et al. [5] in 1994 as a factor associated with the blood 
pressure levels. Later the presence of such association 
was described in number of other ethnic groups: Finns [6], 
Russians [7], and Chinese [8]. According to our co-workers’ 
data the association of blood pressure level and A1166C 
polymorphism exists also among residents of Vinnytsia 
region [9, 10].
Available information about the impact of the poly-
morphic ATR1 gene structure on central pulse wave is 
scarce and contradictory. Gardier S. et al. in 2004 found 
that the higher pulse velocity the more allele A number 
ATR1 gene contains. In contrast Benetos et al. (1996 and 
2010) indicated that carriers of alleles C had had higher 
PWV than allele A carriers. The above-mentioned cir-
cumstances provided the stimuli to conduct this study.
The objective was to establish a possible association 
of A1166C polymorphism of ATR1 gene with the pulse wave 
parameters obtained by applanation tonometry.
Material and methods
We examined male and female untreated adult persons 
aged 25 to 76 years. They were divided into two groups: 
the essential hypertension (EH) group consisting of 150 
hypertensive patients and the control group (CG) presen-
ted by 128 individuals with normal blood pressure. The 
study was approved by the local ethic committee. All the 
participants gave their informed consent to take part in the 
study. Also we received the informed consent for genetic 
analyses signed by every person. During the period from 
August to November in 2013 all consequent persons who 
met inclusion-exclusion criteria and gave their informed 
consent were involved in our study. Inclusion criteria were 
as follows: males and females aged 25 or more with essen-
tial hypertension or without history of arterial hypertension. 
Exclusion criteria were as follows:
 — congenital or acquired heart defects;
 — systemic connective tissue diseases;
 — endocrine diseases excluding diabetes mellitus;
 — diabetes mellitus of type 1 or uncontrolled DM of type 2;
 — chronic kidney diseases;
 — secondary arterial hypertension;
 — cardiopathies of any genesis including myocardial 
infarction;
 — pulmonary hypertension;
 — hemodynamically significant arrhythmias including 
persistent AF, atrioventricular or sinoatrial blocks of 
II–III degree;
 — unstable or variant angina at the day of involvement;
 — history of stable treatment of hypertension during the 
last month before involvement.
General clinical examination and three-fold measu-
rements of systolic and diastolic blood pressure (SBP 
and DBP, respectively) with an automatic blood pressure 
monitor Omron M3 were obligate. The structure of the poly-
morphic receptor gene ATR1 was defined in all participants 
by polymerase chain reaction on the thermocycler PHC 
(Techne, UK). Genomic DNA was extracted from venous 
blood leukocytes by the phenol-chloroform extraction. Spe-
cific sites were labeled using primers for complementary 
completion of DNA strands at the particular starting block. 
Amplification consisted of three stages: the untwisting of 
the DNA double helix (denaturation), joining the primers 
and the complementary completion of DNA strands. Assem-
bling of new DNA strands was provided by a thermostable 
DNA polymerase Taq, manufactured by NPO Biotech. Am-
plifications were carried on using the following program: 
a first cycle — 94°C/3 min., 35 cycles — 94°C/1 min., 
65°C/1 min., 72°C/2 min., last cycle — 72°C/6 min. Am-
plification products were separated by electrophoresis on 
2% agarose gel stained with ethidium iodide. It is known 
that the C allele of 1166 gene can be cleaved to fragments 
of the size 114 and 238 np when allele A 1166 remains 
uncleaved. The presence of a fragment of 352 np after 
processing with a restriction enzyme corresponded to geno-
type AA, two fragments (114 bp and 238) — CC genotype, 
three (114, 238 and 352 np) — heterozygote AC.
Pulse wave analysis was provided with the applanation 
tonometry by Sphygmocor XCEL equipment (AtCor Medical, 
Australia). Pulse wave curve of the radial artery was obtained 
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with Hi-Fi applanation probe. Then the aortic pulse wave 
curve generated automatically.
We obtained following parameters:
 — AIx (P2/P1) — augmentation index calculated by the 
formula: AIx = (100 × (P2 – Pd))/(P1 – Pd) (1) wherein 
Pd — end-diastolic pressure; P1 — end-systolic pressure; 
P2 — pressure augmentation wave height;
 — AIx (AP/PP) — augmentation index calculated as the 
ratio of augmentation pressure to pulse pressure at 
the end of ventricular systole;
 — AIx75 — augmentation index calculated by the previous 
formula, but standardized to the heart rate of 75 per 
minute;
 — CESBP— central end-systolic blood pressure;
 — CSBP — central systolic blood pressure;
 — CDBP — central diastolic blood pressure;
 — PPA — pulse pressure augmentation. It was calculated 
by the formula: PPA = (SBP – DBP)/(CSBP – CDBP)
Next we determined pulse wave velocity (PWV) in the 
carotid-femoral segment of aorta. First of all, the distan-
ces between the best pulsations of carotid and femoral 
arteries and sternal notch were measured by measuring 
tape. Then the pulse waves synchronized with the ECG 
were consequently recorded at these points. Knowing the 
length of the carotid-femoral arterial segments and the 
carotid-femoral delay of pulsations, the pulse wave velocity 
(PWV) was calculated.
Statistical methods
All values are presented as mean (SD). Non-parametric 
methods for dependent and independent samples were 
used to compare the results. Comparison of prevalence 
of ATR1 gene’s variants was performed using frequency 
tables and χ2-criterion. ANOVA was used to analyze the 
differences in pulse wave parameters depending on ATR1 
gene polymorphism. Statistical processing was performed 
using the application Statistica 8.0.
Results
The data obtained in the hypertensive and control groups 
are presented in Table 1.
They showed that the mean age and body weight of the 
control group had been less than in hypertensive patients, 
although height and gender differences within groups were 
not significant. The mean duration of hypertension in EH 
group was 12.9 years, interquartile range 5–18 years. 
Thirty two of patients (21%) have had hypertension of 1nd 
grade, 102 (68%) — of 2nd grade and 16 (11%) — of 3rd grade 
according to recommendations of ESC and Polish Society 
of Hypertension (2015) [11].
The incidence of different variants of the polymorphic 
gene structure ATR1 in persons with normal and high 
blood pressure were in accordance with Hardy-Weinberg 
equilibrium. They are shown in Table 2. In both groups (the 
control group and the group of hypertensive patients) CC 
genotype incidence was the lowest. At the same time the 
prevalence of genotype CC and allele C among hyperten-
sive patients was significantly higher than among those 
with normal blood pressure (p < 0.001) according to the 
criterion χ2 with Yates’ correction.
Analysis of mean SBP and DBP in dependence on 
ATR1 genotype and existence of arterial hypertension 
showed that they were likely to have risen with increasing 
number of C allele (Fig. 1, 2).
However, statistical significance of the trend was confir-
med by ANOVA only for SBP in patients with hypertension.
The differences of standard pulse wave parameters 
depending on the structure of the gene polymorphism 
ATR1 were also analyzed by ANOVA (Tab. 3).
Significant differences in CDBP and PPA in hypertensive 
patients compared with normotensive were revealed. Also 
a tendency to decrease CDBP and PPA with increasing 
Table 1. Demographic, anthropometric and clinical characteri-
stics of the control and basic groups
Parameters Control group Basic group
Quantity 128 150
Males [%] 56 62
Age [years] (SD) 39.2 (15.7) 58.6 (10.8)*
Height [cm] (SD) 172 (9) 170 (9)
Body mass [kg] (SD) 73 (16) 88 (18)*
SBP [mm Hg] (SD) 122 (11) 153 (22)*
DBP [mm Hg] (SD) 71 (8) 87 (14)*
LV hypertrophy [%] – 34.0







Retinal disinsertion [%] – 0.7
*Probability of differences based on Mann-Whitney test p < 0.01; SD — standard deviation
Table 2. The prevalence of polymorphic variants of ATR1 gene 
among normotensive (the control group) and hypertensive (the 
basic group) subjects
Control group (n = 128) Basic group (n = 150)
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number of C alleles was found. The subjects of the control 
group demonstrated no significant differences in most of 
parameters, except PPA that showed the same trend as in 
the group of hypertensive patients. Figure 3 demonstrates 
such patterns.
Thus, we established the association between the 
decrease of PPA and increase of C alleles’ number in the 
ATR1 gene.
Figure 1. Mean systolic blood pressure (SBP) in hypertensive 
(BG, basic group) and normotensive (CG, control group) subjects 
depending on polymorphism of ATR1 gene; AA, AC, CC — genotypes
Figure 2. Mean diastolic blood pressure (DBP) in hypertensive 
(BG, basic group) and normotensive (CG, control group) subjects 
depending on polymorphism of ATR1 gene; AA, AC, CC — genotypes
Table 3. Parameters of aortic pulse wave depending on ATR1 genotype
Parameters АА (n = 83) АС (n = 39) СС (n = 6)
Control group
AIx (AP/PP) 10.0 (8.4) 17.2 (10.3) 16.4 (16.2)
AIx (P2/P1) 111.0 (12.9) 125 (13.4) 122 (19.1)
AIx75 1.0 (6.9) 10.9 (11.1) 10.0 (13.4)
CESBP [mm Hg] 88.8 (14.3) 99.2 (15.1) 94.3 (18.3)
CSBP [mm Hg] 91.2 (9.3) 100.1 (10.0) 94.8 (16.2)
CDBP [mm Hg] 77.2 (7.2) 83.5 (6.9) 82.7 (9.4)
PPA [mm Hg] 3.4 (0.2) 3.2 (0.2) 3.0 (0.4)*
PWV [m/s] 5.3 (2.2) 6.4 (1.9) 6.6 (3.3)
Parameters АА (n = 43) АС (n = 74) СС (n = 33)
Basic group
AIx (AP/PP) 26.2 (9.1) 28.8 (7.5) 36.8 (9.2)
AIx (P2/P1) 138.6 (12.8) 141.8 (12.4) 165.5 (13.2)
AIx75 24.4 (6.3) 26.8 (5.9) 32.4 (7.8)
CESBP [mm Hg] 133.3 (15.2) 121.6 (14.4) 134.1 (17.3)
CSBP [mm Hg] 129.2 (9.5) 120.2 (9.4) 131.8 (10.4)
CDBP [mm Hg] 109.5 (10.0) 97.4 (9.7) 102.0 (10.1)*
PPA [mm Hg] 3.4 (0.3) 3.0 (0.2) 2.7 (0.3)*
PWV [m/s] 9.2 (2.4) 9.3 (2.1) 9.6(2.9)
*Probability of differences based on Kruskal-Wallis criterion p < 0.05
Discussion
According to the study design, all participants were invol-
ved consequently when they had met appropriate criteria. 
That’s why there were some differences in mean age and 
body mass within groups. We suggest that these differences 
reflected the role of age and body mass as risk factors of 
hypertension.
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The lower border of age (25 years) had separated the 
period of youth from the period of adultness according to 
the World Health Organization (WHO) criteria.
The study found that in hypertensive patients the inci-
dence of allele C and CC genotype was significantly more 
pronounced than in the control group. These results are 
consistent with data of other researchers. According to 
the meta-analysis summarizing the results of 30 studies 
carried out in different ethnic groups in China, the presence 
of gene A1166C allele increases the risk of hypertension 
in 1.48 times [8]. Association of allele C carrying with 
hypertension was established in hypertensive patients of 
Poltava region of Ukraine [12].
As we mentioned before, some researchers have poin-
ted to the association of polymorphic gene ATR1 structure 
with PWV. The above-mentioned association was determi-
ned not only in the European population, but also among 
the Asian, particularly in the Malays [13]. Moreover, the 
researchers marked not only the association of allele C 
with a higher PWV, but also more pronounced growth of 
PWV in long-term (16 years) follow-up of allele C carriers 
[14]. However, according to our data, most of the pulse 
wave parameters including the PWV did not demonstrate 
such associations neither among hypertensive patients nor 
among the control group.
At the same time our study found a slight increase 
in brachial blood pressure with the number of C alleles, 
which was consistent with the results of a large number 
of previously published studies. Therefore, it was expec-
ted that the value of CESBP, CSBP and CDBP would also 
increase with the number of alleles C. But the central 
blood pressure in carriers of different gene ATR1 structure 
differed insignificantly contrary to the expectations. At the 
same time a significant change in both the peripheral and 
central pulse pressure in carriers of different gene variants 
of ATR1 was identified. Moreover, according to our data, 
PPA has been decreasing with the increasing number of 
C alleles. Since the PPA reflects the ratio of the peripheral 
and central pulse pressure, we suggest that the decrease 
of PPA indicates that the owners of C alleles have a greater 
contribution of the central mechanisms of hypertension, 
while individuals with AA genotype have more prevalent 
peripheral. In such case the definition of the PPA may have 
some prognostic meaning concerning the management of 
hypertension.
Conclusions
Thus, the study showed the higher prevalence of CC ge-
notype and allele C of gene A1166C among hypertensive 
patients compared with normotensives. Such carriage was 
accompanied with the significant increase of brachial blood 
pressure in the absence of significant differences in the 
levels of central BP. At the same time we revealed some 
decrease in pulse pressure augmentation that could serve 
simultaneously as a marker of the presence of C alleles 
and more pronounced influence of the central (cardiac and 
aortic) mechanisms of hypertension.
Limitations
Control group in our study was younger than patients with 
EH. Thus, we avoided age-related comparisons of groups 
and analyzed only differences associated with ATR1 gene 
polymorphism. Nevertheless, the influence of age in sub-
groups with definite gene polymorphisms was not excluded.
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Figure 3. Mean pulse pressure augmentation (PPA) in hypertensive 
(BG, basic group) and normotensive (CG, control group) subjects 
depending on ATR1 genotype; AA, AC, CC — genotypes
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Streszczenie
Wstęp. Dostępne informacje na temat wpływu polimorfizmu genu receptora angiotensyny typu 1 (ATR1) na centralną 
falę tętna są nieliczne i sprzeczne. Badanie przeprowadzono w celu ustalenia możliwych związków między polimorfi-
zmem A1166C genu ATR1 a parametrami fali tętna uzyskanymi metodą tonometrii aplanacyjnej.
Materiał i metody. Autorzy objęli badaniem kobiety i mężczyzn w wieku 25–76 lat. Badanych podzielono na dwie grupy 
— grupę podstawową złożoną ze 150 chorych z nadciśnieniem tętniczym i grupę kontrolną utworzoną ze 128 osób z pra-
widłowym ciśnieniem. U wszystkich chorych, poza ogólnym badaniem klinicznym, przeprowadzono 3-krotne pomiary 
ciśnienia skurczowego (SBP) i rozkurczowego przy użyciu automatycznego monitora ciśnienia Omron M3. U wszystkich 
uczestników określono strukturę genu receptora ATR1, stosując reakcję łańcuchową polimerazy w termocyklerze PHC 
(Techne, Wielka Brytania). Analizę fali tętna przeprowadzono metodą tonometrii aplanacyjnej. W tym celu użyto urzą-
dzenia Sphygmocor XCEL (AtCor Medical, Australia).
Wyniki. Analiza średnich wartości SBP i DBP zależnie od genotypu ATR1 i obecności nadciśnienia tętniczego wykazała 
trend w kierunku wzrastania tych wartości wraz ze zwiększającą się liczbą alleli C, jednak istotność statystyczną trendu 
potwierdzono w analizie ANOVA tylko w przypadku SBP u chorych z nadciśnieniem tętniczym. Wykazano również istotną 
różnicę pod względem wartości centralnego ciśnienia tętniczego (CDBP) i wzmocnienia ciśnienia tętna (PPA) między 
chorymi z nadciśnieniem a osobami z prawidłowym ciśnieniem tętniczym. Stwierdzono trend w kierunku zmniejszania 
się wartości CDBP i PPA wraz z rosnąca liczbą alleli C. U osób z grupy kontrolnej wykazano taki sam trend w odniesieniu 
do wartości PPA jak w grupie z nadciśnieniem tętniczym.
Wnioski. Autorzy ustalili związek między zmniejszaniem się wartości PPA a zwiększającą się liczbą alleli C w genie ATR1.
Słowa kluczowe: polimorfizm A1166C, związek, analiza fali tętna, chorzy z nadciśnieniem i prawidłowym ciśnieniem 
tętniczym
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